Try our Advanced Search for more refined results
Life Sciences - June, 2009
154 articles
- Some Alzheimer's Claims Tossed In Mayo Patent Suit
- Medtronic Sues Insurer For Worker Theft Court Costs
- Solvay, Unimed Hit With AndroGel Suit In Pa.
- EU To Consider Concessions In Pfizer, Wyeth Review
- Abbott Hit With $1.7B Verdict In IP Suit Over Humira
- Forest Derivative Appeal Halted As Sides Seek Deal
- Alcatel, Pfizer Still Owe Landfill Cleanup Costs: EPA
- Dismissal Of AstraZeneca Securities Action Upheld
- BioMedica's Review Bid Denied In Nordic Patent Suit
- Schering To Pay $55M To Settle AWP Suit
- FDA Enforcement Crackdown Requires Reforms
- Water Board's Merck Discharge Limit Appealed
- Top Fed. Circ. Rulings That Came Down Last Quarter
- Roche To Stop Selling Accutane In US
- Device Maker Prevails In Pain Pump Suit
- Medtronic Accepts $179M Judgment In Screw Case
- Daiichi Sankyo Attacks Apotex Over Evoxac ANDA
- PR Campaign For IP Can Give Firms A Boost
- USPTO Upholds Rembrandt Contact Lens Patent
- Lilly Scores 3 More Zyprexa Dismissals In MDL
- FDA To Pull Immucor's Biologics License
- Novo Settles Danish Oil-For-Food Probe For $5.7M
- FDA Blasts Medtronic Over Slow Drug Pump Recall
- Tug-Of-War Over Expert In Viagra Litigation Continues
- Ariz., Drugmakers Settle Fraud Claims In AWP Suit
- Abbott Sues Former Manager, Ev3 Over Trade Secrets
- FTC Says Authorized Generics Can Aid Competition
- Ky. Jury Finds Sandoz Liable For $16M In AWP Case
- US Marshals Seize Caraco Drugs In FDA Action
- New Plaintiffs Try To Revive Medtronic ERISA Action
- St. Jude Valve Plaintiffs Lose Bid For Class Cert.
- Insurance Deal Adds $6M To Quigley Asbestos Trust
- Teva Blasts FTC's Position On Pay-For-Delay
- St. Jude Investors Can't Alter Loss Theory: Judge
- AstraZeneca Strikes Out Again Over Seroquel Expert
- Sequenom Faces Slew Of Shareholder Suits
- SEC Probes Matrixx Following FDA Zicam Warning
- Humana Officers Prevail In Shareholders' Suit
- Sequenom, Beckman Drop DNA Analysis Patent Suit
- Rembrandt Vision Sues J&J Over Contact Lens Patent
- Jones Day Lures Former FTC Competition Head
- Bill Aims To Expand ANDA First Filer Exclusivity
- Pfizer Celebrex Suit Stayed Pending High Court Case
- Mailer 'Misleads' About Cancer Drug's Efficacy: FDA
- Merck Moves To Block Challenge To Vioxx Settlement
- Galil Sues HealthTronics In Endocare Merger Spat
- Rebate Discovery To Proceed In TriCor Antitrust Suit
- EU To Reveal Bank Guidance, Pharma Findings: Report
- Fla. Appeals Court Blocks Mylan's Generic Synthroid
- FTC Chief Says Generic-Drug Deals Cost Public $3.5B
- 8th Circ. Says P&G, Others Can't Jump Into CWA Suit
- Obama Taps Judges From Ga., NJ For Circuit Courts
- High Court Won't Hear 'Reverse Payment' Challenge
- U Of Iowa Says Abbott's Humira Infringes Patents
- FTC Issues 2nd Request In Merck-Schering Merger
- States Join Qui Tam Medicaid Suits Against Wyeth
- Novo's Suit Over Prandin ANDA Survives Bid To Toss
- Fen-Phen Attys Ordered To Pay Feds $30M
- AstraZeneca Loses Bid To Ban Seroquel MDL Expert
- Dismissal Of Baycol Failure-To-Warn Suit Upheld
- Ex-Pfizer Sales Manager Sentenced For Bextra Charge
- Trucking Co.'s Liability Capped In Drug Shipment Loss
- Veteran White Collar Atty Returns To Fox Rothschild
- FDA Staff Recommends Study Of Abbott Seizure Drug
- Matrixx Braces For More Zicam Smell-Loss Suits
- EU High Court Clarifies Generics Question In J&J Case
- Ethicon Ex-Employee Enjoined In Patent Spat
- Off-Label Marketing MDL Over Amgen Drugs Nixed
- CVS Unit's E-Ferol Insurance Spat Moved To Texas
- Generics Triumph Over Sanofi In Cancer Drug Quarrel
- Foley Settles Malpractice Suit Over Vaxiion Patent
- Sepracor Sues Synthon Over Oral Xyzal ANDA
- Cancer Suits Over Novartis Eczema Drug Remanded
- GSK Lamictal Prices Don't Breach Deal, Judge Says
- Doctor's Testimony In Own Baycol Suit 'Inadmissible'
- Genentech Can't Follow Up Rituxan Alone: Arbitrators
- Norian, Synthes Charged With Illegal Human Tests
- Pharma Processor Settles EPA Emissions Claims
- Pfizer Ratchets Up Lyrica IP Suit Against Sun Pharma
- Ethicon Asks To Protect Patent Apps After $2M Verdict
- FDA Says Zicam Nose Products Cause Loss Of Smell
- Genzyme Halts Production At Mass. Plant Over Virus
- Pfizer Takes On Mylan In Fight To Protect Lipitor
- $100M Deal Over Combe Fill Superfund Site Finalized
- Dey Joins In Spoliation Cries In Drug Price MDL
- Bristol-Myers Nears Deal In Plavix Securities Suit
- GSK, P&G Head For Fla. In Denture Cream MDL
- Mayer Brown Grabs IP Trio From McDermott Will
- Calif., IBM Granted Most US Patents In 2008
- Stay Granted In Lipitor Case Pending Del. Decision
- Wyeth Places Heavier Burden On Implied Preemption
- Novo Warns Users Of Stolen Shipment Of Insulin
- FDA Orders Psychiatric Warn Labels On Asthma Drugs
- Medicis Hits Ranbaxy With Acne Drug Patent Suit
- Allen & Overy Snags DLA, Wragge Attys For IP Group
- StarCaps False Advertising Suit Can Go Forward
- 11th Circ. Finds For Roche In Accutane Suicide Suit
- FDA Strengthens Gardasil Label's Fainting Warning
- Calif. AG, CVS Settle Inquiry Into Expired Products
- FDA Recalls 21,000 Faulty Medtronic Pacemakers
- African Drug Importer Accused Of $1.2B Ponzi Scheme
- Medical Device Maker Merger Battle Moves To Court
- Treating Physician V. Expert Witness
- FDA Should Regulate Biologic Generics: FTC Report
- Fed. Circ. Trims Daiichi Costs Award In Levaquin Suit
- Purdue Settles OxyContin Patent Cases Against KV
- FDA Panel Says Seroquel OK For Teens
- Blackwell V. Wyeth: The Application Of Frye
- SEC Sues Swiss Man Over Illicit Trading In GSK Deal
- Fed. Circ. Revives Varian Radiation Patent Fight
- NAACP Seeks Class Cert. In Lilly Race Bias Suit
- Plaintiffs Want Pfizer Celebrex Docs Unsealed
- Widow's Suit Over Wyeth Arthritis Drug Tossed
- Eli Lilly Moves To Toss Zyprexa Battle With Conn.
- Allergan Launches 2nd Suit Over Combigan Patents
- Supreme Court Asks For SG's Take On Vaccine Suit
- CSL, Talecris Call Off $3.1B Deal Amid FTC Pressure
- Reckitt Hits Watson Again Over Mucinex ANDAs
- Abbott Accuses DOJ Of 'Massive' Spoliation
- Actavis Seeks To Narrow Subpoena In Digitek MDL
- Lawmakers Slam FTC Generic Biologic Report
- Supplement Maker Sues Rival Over Disparaging Claims
- ACLU Suit Spurs Debate Over Gene Patents
- Staying On Top Of Electronic Data In IP Cases
- Texas Court Affirms Tossing Of $26M Vioxx Judgment
- Judge OKs Synergetics Tying Claims Against Alcon
- Genentech — Where Do We Go From Here?
- WL Gore Indefiniteness Defense Shot Down In IP Suit
- GSK, Inventor Urge Fed. Circ. To Review Tafas V. Doll
- Teva Access To Pfizer Docs On Detrol Restricted
- Lilly Wins 2 Summary Judgment Bids In Zyprexa MDL
- Gilead Shareholders Must Amend Suit For 5th Time
- FDA Finds Liver Risk In Generic Graves' Treatment
- The New Geography Of Patent Litigation
- Schering Contractors' Trade Secrets Spat Revived
- Walgreen To Pay $1.4M To End Cold Remedy Ad Suit
- P&G, McNeil-PPC Settle Teeth-Whitening Patent Spat
- P&G, AstraZeneca Sued Over Prilosec OTC Risks
- Wyeth Workers Seek Summary Judgment In FLSA Suit
- Suit Claims Teva's Wellbutrin Generic Is Inferior
- On Securities, Sotomayor Sticks To 'Nuts And Bolts'
- Mayer Brown Puts Associates To Work In-House
- FDA Takes Step Toward Increased Transparency
- IP Attys Hail Cert Grant On Bilski
- Fed. Circ. Cuts $226M Award In Medtronic Screw Suit
- 3rd-Party Microsoft Claims Survive In Web Patent Suit
- Blood Reagent Buyers Put J&J, Immucor In Hot Seat
- Bid To Replead Medtronic Securities Suit Denied
- Contact Lens Cleaner Settlements Cost Bausch $250M
- Eastern Texas After TS Tech, Awaiting Genentech
- Discrimination V. Whistleblower Claims
- Fed. Circ. Rules Enbrel Doesn't Infringe Ariad Patent
- FTC Pushes Congress To Pass Drug Settlement Bill
- Dueling Patents Partly Invalidated In Lexapro Row